Haematologica Early View: Omid Seidizadeh Explores Genetics Behind Clinical Variability in Type 2 VWD
Omid Seidizadeh, Research Leader of the A. Bianchi Bonomi Hemophilia and Thrombosis Center, has shared a post on LinkedIn:
“Delighted to see our study on the genetic determinants of clinical variability in type 2 von Willebrand disease now out as Early View in Haematologica Journal
This work highlights how VWF genetic variation influences the clinical expression of different types 2 VWD, and the clinical variability among cases with the same genetic variant.”
Title: Genetic determinants of clinical variability in type 2 von Willebrand disease: bridging genotype and phenotype
Authors: Omid Seidizadeh, Alessandro Ciavarella, Luciano Baronciani, Paola Colpani, Andrea Cairo, Simona Maria Siboni, Flora Peyvandi
Read the article here.
Stay updated in the bleeding disorders field with Hemostasis Today.
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies
-
Aug 10, 2026, 17:35Chokri Ben Lamine: Balancing Holistic Care and Precision in Hematology
-
Aug 10, 2026, 17:14Anna Stanizzi: Patient Blood Management as a New Model of Personalized Care
-
Aug 10, 2026, 17:12Odong Christopher: New Research on Ischemic Stroke Prediction in Uganda
-
Aug 10, 2026, 16:58Jeff Szer AM: Advancing the Management of Paroxysmal Nocturnal Hemoglobinuria
-
Aug 10, 2026, 16:51Suebsarn Ruksakulpiwat։ A New Milestone in the Development of the Stroke Risk Screening Scales
-
Aug 10, 2026, 16:09Preetie Shetty Akkunje: Making Stroke Rehabilitation Accessible in Low-Resource Settings
-
Aug 10, 2026, 15:50The Next Antithrombotic Frontier: GPVI Inhibitors Beyond Aspirin
-
Aug 10, 2026, 15:47Edward Lee Carter: 61% of Patients on Reduced-Dose Apixaban Did Not Meet Label Criteria